Answers to some of the biggest questions facing ophthalmology will be discussed at Australia’s first Advances in Ophthalmology event hosted by RANZCO later this year.
Following the success of its full virtual congress in February, the college’s new one-day conference will also be delivered digitally, discussing various topics including artificial intelligence (AI), gene therapy and bioengineered corneas.
Taking place on Saturday 10 September 2022, the event is open to all and will be convened by Sydney-based ophthalmologists Professor Peter McCluskey and Associate Professor Clare Fraser.
Ultimately, it aims to uncover what the next five years of ophthalmic developments will mean for members of the eyecare team, and their patients and communities.
Ophthalmologists will be asked to consider how these developments and advances will affect the practice of ophthalmology. And, more importantly, how they can harness such change to improve the lives of the communities they serve.
The conference will feature panels, debates and live interaction and Q&A. Discussions include:
- Professor David Mackey explores if self-driving cars will ever be suitable for the vision impaired.
- Professor Gerard Sutton questions if a bioengineered cornea would work.
- Concluding the program will be a debate on AI and what it means for ophthalmologists, patients and the community.
Attendees will also gain a better understanding of stem cell Rx and antimicrobial stewardship.
This is the first time RANZCO has organised an Advances in Ophthalmology event, with plans to run it again as an in-person meeting in the first half of 2023.
Event information is available on the Advances in Ophthalmology website. Registration is now open.
More reading
RANZCO Congress highlights new horizons in ophthalmology
RANZCO myopia position paper: Why outdoor time is essential
RANZCO appoints Mark Carmichael as new CEO
